NOVELION THERAPEUTICS INC - COM NEW (NVLNF)

CUSIP: 67001K202

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM NEW
Total 13F shares
7,049,577
Share change
-1,078,748
Total reported value
$8,673,290
Put/Call ratio
0%
Price per share
$1.23
Number of holders
24
Value change
-$1,079,297
Number of buys
4
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 67001K202?
CUSIP 67001K202 identifies NVLNF - NOVELION THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVELION THERAPEUTICS INC - COM NEW (NVLNF) as of Q1 2019

As of 31 Mar 2019, NOVELION THERAPEUTICS INC - COM NEW (NVLNF) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,049,577 shares. The largest 10 holders included EdgePoint Investment Group Inc., Healthcare Value Capital, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Broadfin Capital, LLC, JW Asset Management, LLC, Artal Group S.A., Knott David M, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and CITADEL ADVISORS LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.